LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thermo Fisher Presents Cascadion SM Clinical Analyzer and LC-MS IVD Medical Devices at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022
Image: Cascadion SM Clinical Analyzer (Photo courtesy of Thermo Fisher Scientific)
Image: Cascadion SM Clinical Analyzer (Photo courtesy of Thermo Fisher Scientific)

Thermo Fisher Scientific (Waltham, MA, USA) presented its Cascadion SM clinical analyzer and range of LC-MS IVD medical devices at EUROMEDLAB 2022.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is considered the gold standard among vitamin D testing methods, but the technique has traditionally relied on sophisticated technology requiring specialized knowledge. The Cascadion SM clinical analyzer, equipped with a built-in 25-hydroxy vitamin D assay, automatically analyzes vitamin D2 and D3 in blood samples directly from qualified primary blood collection tubes, without the need for extensive technical expertise. Incorporating sample processing, LC separation and MS detection capabilities in a single solution, the Cascadion system is fully automated and enables load-up and walkaway sample management, eliminating the need for multiple connected components. The system offers end-to-end automation that is easy to use by any qualified laboratory personnel with minimal training, thus streamlining and optimizing the analytical process. The clinical analyzer is designed to simplify and accelerate the implementation of LC-MS/MS into routine clinical workflows.

Also on display at EUROMEDLAB 2022 was the Thermo Fisher family of LC-MS instruments for in vitro diagnostics that provides clinical labs with consistent reliable results, faster. These comprehensive, reliable LC-MS platform solutions offer greater flexibility than immunoassays, facilitate cost savings and enable clinical laboratories to achieve their productivity goals, while ensuring confidence in results of laboratory developed tests (LDTs). Thermo Fisher demonstrated the Vanquish MD HPLC which is the ideal chromatographic separations system for laboratories where analyte resolution is critical, alongside the TSQ Quantis MD Series mass spectrometer that is used by clinical diagnostic laboratories to meet routine requirements for laboratory tests. In addition, Thermo Fisher showcased the TSQ Altis MD Series mass spectrometer that is used by clinical diagnostic laboratories to address challenging analyte requirements for LDTs.

Related Links:
Thermo Fisher Scientific

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more